Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 429 for inhibition
Company Exchange Symbol Last price Quote change Market cap
Incyte Corporation NASDAQ INCY 84.21 +2.43 (2.97%) 15.54B
The Company focuses on the research and development program to explore the inhibition of enzymes called janus associated kinases (JAK).
Ionis Pharmaceuticals Inc NASDAQ IONS 22.02 +0.66 (3.09%) 1.61B
Ionis Pharmaceuticals, Inc., formerly Isis Pharmaceuticals, Inc., is engaged in discovering and developing ribonucleic acid-targeted (RNA-targeted) ...
Array Biopharma Inc NASDAQ ARRY 3.58 +0.10 (2.87%) 531.85M
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients ...
Gilead Sciences, Inc. NASDAQ GILD 85.64 +0.35 (0.40%) 112.44B
Gilead Sciences, Inc. is a research-based biopharmaceutical company. The Company focuses on the discovery, development and commercialization of medicines in ...
AstraZeneca plc (ADR) NYSE AZN 29.80 -0.16 (-0.52%) 74.08B
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription ...
Cyclacel Pharmaceuticals Inc NASDAQ CYCC 0.420 -0.009 (-2.03%) 15.11M
Cyclacel Pharmaceuticals, Inc. develops therapies that harness the power of the immune system to treat cancer and other serious illnesses.
Exelixis, Inc. NASDAQ EXEL 6.31 +0.01 (0.18%) 1.46B
Exelixis, Inc. is a biopharmaceutical company. The Company is engaged in developing small molecule therapies for the treatment of cancer.
Rigel Pharmaceuticals, Inc. NASDAQ RIGL 2.48 -0.01 (-0.20%) 224.47M
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted drugs in the ...
Pharmacyclics, Inc. NASDAQ PCYC 0.0000
Pharmacyclics, Inc. is an integrated biopharmaceutical company engaged in developing and commercializing therapies for the treatment of cancer and ...
Pharmasset, Inc. (Inactive) NASDAQ VRUS
Pharmasset, Inc. is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel drugs to treat viral infections.
Celgene Corporation NASDAQ CELG 106.06 +0.28 (0.26%) 82.68B
Celgene Corporation (Celgene) is a biopharmaceutical company. The Company together with its subsidiaries is engaged primarily in the discovery, ...
Rexahn Pharmaceuticals, Inc. NYSEMKT RNN 0.309 +0.011 (3.87%) 66.43M
Rexahn Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of treatments for ...
Arbutus Biopharma Corp NASDAQ ABUS 4.09 -0.17 (-3.99%) 226.61M
Arbutus Biopharma Corporation, formerly Tekmira Pharmaceuticals Corporation, is a therapeutic solutions company. The Company is engaged in discovering, ...
Ligand Pharmaceuticals Inc. NASDAQ LGND 121.19 -0.77 (-0.63%) 2.51B
Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical ...
Ariad Pharmaceuticals, Inc. NASDAQ ARIA 8.14 +0.11 (1.31%) 1.53B
ARIAD Pharmaceuticals, Inc. (ARIAD) is an oncology company. The Company is focused on transforming the lives of cancer patients with medicines.
DAIICHI SANKYO COMPANY, LIMITED TYO 4568 2,577.50 -20.50 (-0.79%) 1.83T
DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in ...
Pfizer Inc. NYSE PFE 34.49 +0.06 (0.16%) 209.69B
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing of healthcare products ...
Sunesis Pharmaceuticals, Inc. NASDAQ SNSS 0.489 +0.019 (4.04%) 40.51M
TAK-580 is an oral, investigative drug selective for pan-Raf kinase inhibition, in patients with relapsed or refractory solid tumors.
ArQule, Inc. NASDAQ ARQL 1.68 +0.03 (2.12%) 117.60M
ArQule, Inc. is a biopharmaceutical company. The Company is engaged in the research and development of therapeutics to treat cancers and rare diseases.
AstraZeneca plc LON AZN 4,021.79 +10.29 (0.26%) 50.96B
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription ...